3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow James Murrough: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Harmine in Healthy Subjects Harmine Hydrochloride Capsules - Diabetes Mellitus | Phase 1 | Completed | James Murrough | 27 | 2022-09-13 | 2025-01-16 |
| A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD) Neuropeptide Y - Posttraumatic Stress Disorder | Phase 1 | Completed | James Murrough | 26 | 2012-12-01 | 2016-04-14 |
| Continuation Ketamine in Major Depression Lithium, Ketamine - Major Depressive Disorder | Phase 1 | Completed | James Murrough | 36 | 2007-10-01 | 2014-05-23 |
Depressive Disorder, Major (1) · Diabetes Mellitus (1) · Stress Disorders, Post-Traumatic (1) · Wounds and Injuries (1)
Ketamine (1) · Lithium (1) · Lithium Carbonate (1) · Neuropeptide Y (1)
United States (3)
PMID 19545857, PMID 19897179, PMID 21450159, PMID 25271445, PMID 29186416, PMID 39301926
R01DK128242 (1)